Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5 Reasons to Buy Chewy Stock Hand Over Fist

In This Article:

Leading online pet-products retailer Chewy (NYSE: CHWY) has seen its share price rocket 56% higher over the last month. This run might have investors thinking they missed their opportunity to buy shares in the newly profitable business.

However, even after growing its net profit margin from negative 9% in 2018 to 2.3% in its last quarter, Chewy could still be in the early stages of its margin expansion with a focus on higher-margin businesses. Here are five reasons Chewy could see its profitability continue to move higher for years to come, making it an excellent stock to buy hand over fist.

1. Chewy Health

The company has built a $3 billion pet healthcare business named Chewy Health, in addition to its traditional retail sales of pet food and toys. It sells prescription and over-the-counter medicines, supplements, and veterinary diets, and now accounts for roughly 30% of the company's sales.

These pet health products, used by 20% of the company's customers, have a gross profit margin 10 percentage points higher than its retail business.

Here's where things get really interesting for Chewy Health's potential, though. It is already the No. 1 pet pharmacy in the U.S., but the company has ample opportunity to continue growing its share of the pet healthcare niche as it opens veterinary clinics.

2. The vet clinics

Chewy launched its move into the veterinary space with its first four pet-care clinics in its latest quarter. These clinics could bring new customers to Chewy's platform while furthering its margin expansion. Today's Veterinary Business estimates that the average vet clinic in the U.S. maintains a net profit margin north of 10%, a far cry from Chewy's current 2.3% mark.

This expansion might be welcomed by pet owners and veterinarians alike, given its No.1 spot on Forrester's Customer Experience Index. With private equity shops scooping up roughly 25% of the vet clinics in the U.S. (despite negative views about it among veterinarians and pet owners alike), Chewy could disrupt an industry now viewed as overly profit-focused.

A young black and brown puppy lies amid a pile of cash.
Image source: Getty Images.

3. CarePlus pet insurance

The company recently partnered with Trupanion and Lemonade to offer health and well-being insurance for pets, an industry that has grown to roughly $4 billion today. The pet medical insurance niche is expected to increase by 17% annually through 2027, with only 3% of pet owners using such an offering, giving Chewy a long growth runway.

Best yet for investors, these insurance sales have no underwriting risk to Chewy and bring nearly 100% gross profit margins due to the terms of its partnerships.

Waiting for permission
Allow microphone access to enable voice search

Try again.